Edith Willscher
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Single-cell and spatial transcriptomics 5
-
- COVID-19 Clinical Research Studies 7
- SARS-CoV-2 and COVID-19 Research 6
- Co-authors
- Mascha Binder (21 shared papers)Lisa Paschold (16 shared papers)Christoph Schultheiß (15 shared papers)Hans Binder (12 shared papers)Mario Colombo‐Benkmann (3 shared papers)Wolf Arif Mardin (3 shared papers)N. Senninger (3 shared papers)Soeren Torge Mees (3 shared papers)
- Journals
- PLoS ONE (2 papers)International Journal of Molecular Sciences (2 papers)Hepatology Communications (2 papers)Cancers (2 papers)Haematologica (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Edith Willscher
44 papers receiving 1.4k citations
Edith Willscher's Hit Papers
Peers
Comparison fields: 5 of 110
- Cancer Research 270
- Infectious Diseases 332
- Neurology 259
- Immunology 153
- Molecular Biology 505
Countries citing papers authored by Edith Willscher
This map shows the geographic impact of Edith Willscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edith Willscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edith Willscher more than expected).
Fields of papers citing papers by Edith Willscher
This network shows the impact of papers produced by Edith Willscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edith Willscher. The network helps show where Edith Willscher may publish in the future.
Co-authors
The 25 scholars most cited alongside Edith Willscher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The IL-1β, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19 Hit paper breakdown → | 2022 | 266 |
| 2 | 2020 | 212 | |
| 3 | 2009 | 115 | |
| 4 | 2009 | 109 | |
| 5 | 2011 | 86 | |
| 6 | 2007 | 64 | |
| 7 | 2016 | 59 | |
| 8 | 2022 | 53 | |
| 9 | 2010 | 46 | |
| 10 | 2016 | 45 | |
| 11 | 2020 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2016 | 28 | |
| 14 | 2021 | 26 | |
| 15 | 2014 | 19 | |
| 16 | 2020 | 17 | |
| 17 | 2014 | 17 | |
| 18 | 2018 | 15 | |
| 19 | 2022 | 13 | |
| 20 | 2019 | 13 |
About Edith Willscher
Edith Willscher is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Immunology and Oncology, having authored 45 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Single-cell and spatial transcriptomics (5 papers), Long-Term Effects of COVID-19 (4 papers), Glioma Diagnosis and Treatment (4 papers), Cancer Cells and Metastasis (3 papers), COVID-19 and Mental Health (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (270 citations), Infectious Diseases (332 citations), Neurology (259 citations), Immunology (153 citations) and Molecular Biology (505 citations). Edith Willscher has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Mascha Binder, Lisa Paschold, Christoph Schultheiß, Hans Binder, Mario Colombo‐Benkmann, Wolf Arif Mardin, N. Senninger, Soeren Torge Mees, Jochen Dutzmann and Daniel Sedding. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Hepatology Communications, Cancers and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.